VJHemOnc is committed to improving our service to you

COMy Virtual 2020 | A CAR-T round-up with Arnon Nagler

VJHemOnc is committed to improving our service to you

Arnon Nagler

CAR T-cell therapy is revolutionizing the treatment of hematological malignancy. Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, discusses CAR-T approaches to the treatment of acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL), follicular lymphoma and multiple myeloma,. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter